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Supplemental Material, Figure Table S1 . Relative abundance of typical gut bacterial families in the measurements for control and arsenic exposed mice. a The "Other" assignments are typically due to ambiguity when the RDP classifier tries to assign at the desired level. The "f_" or "f_unassigned" means that it matches a reference sequence, but that reference sequence is not well defined. b The mean and standard errors were calculated using the statistical tool of Metastats. Supplemental Material, Figure S1 . The integration approach combining 16S rRNA gene sequencing and mass spectrometry-based metabolomics profiling to explore the impact of arsenic exposure on the gut microbiome and its metabolomic profile.
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Supplemental Material, Figure S2 . The taxonomic assignments of gut bacterial families, obtained using the Ribosomal Database Project classifier, with each color representing an individual bacterial family (A). Predominant gut bacteria at phylum level revealed by 16S rRNA sequencing, with p_Firmicutes and p_Bacteroidetes being the top 2 phyla (B).
Supplemental Material, Figure S5 . The influence of arsenic-induced gut microbiome perturbations on the formation of some typical gut-flora-generated fecal and urine metabolites.
Indole derivatives were significantly regulated during exposure, with indolepropionic acid, indoxyl and others being increased in urine (A); Alterations of several isoflavone metabolites also clearly illustrate the effects of arsenic-induced gut flora changes, with daidzein and dihydrodaidzein being down-regulated, and O-desmethylangolensin and dihydrogenistein being up-regulated in feces and urine, respectively (B).
